DBV Technologies | DBVT - Ordinary Share Capital

Stock Price
19.80
Daily Change
0.46 2.38%
Monthly
-2.32%
Yearly
132.12%
Q2 Forecast
19.35

DBV Technologies reported $136.82M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 169.18M 470K Dec/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Amarin USD 20.81M 13K Dec/2025
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
DBV Technologies USD 136.82M 51.98K Sep/2025
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Galectin Therapeutics USD 61K 0 Dec/2023
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Insmed USD 214.26M 1.67M Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Neurocrine Biosciences USD 100.1M 400K Dec/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
United Therapeutics USD 43.64M 740K Dec/2025